Yeah, About Time.
NIMH Offers Grants to Study SSRI relation to Suicidality_FDA to Examine SSRI- Suicide in Adults
Mon, 14 Nov 2005
A fifteen year struggle by critics of the drug-centered treatment paradigm in psychiatry is being indirectly validated both by the FDA and the National Institute of Mental Health who are addressing the issue of SSRI and suicide publicly.
The FDA is planning a year long study of the evidence of SSRI antidepressants and the risk of suicide in adults. The first advisory committee hearing of the Drug Safety and Risk Management Advisory Committee is scheduled for December 8-9. See: http://www.fda.gov/cder/drug/advisory/SSRI200507.htm
Mon, 14 Nov 2005
A fifteen year struggle by critics of the drug-centered treatment paradigm in psychiatry is being indirectly validated both by the FDA and the National Institute of Mental Health who are addressing the issue of SSRI and suicide publicly.
The FDA is planning a year long study of the evidence of SSRI antidepressants and the risk of suicide in adults. The first advisory committee hearing of the Drug Safety and Risk Management Advisory Committee is scheduled for December 8-9. See: http://www.fda.gov/cder/drug/advisory/SSRI200507.htm
posted by TheFuriousGourmet | 2:17 PM
0 Comments:
Post a Comment
<< Home